Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
Scribd Logo
Upload

Welcome to Scribd!

  • 33 views

    Sun Pharma

    Uploaded by

    Suman Sourav
    This document provides an overview of Sun Pharma, the world's 5th largest pharmaceutical company, and discusses key drivers of global pharmaceutical demand and spending. It notes that global pharmaceutical spending is expected to grow to $1400-1430 billion by 2020, driven primarily by improved access and treatment in emerging markets, aging populations, and the treatment of chronic diseases. Developed markets will continue to account for over 60% of global spending, led by the United States.

    Copyright:

    © All Rights Reserved
    Download as PPTX, PDF, TXT or read online from Scribd

    Sun Pharma

    Uploaded by

    Suman Sourav
    33 views24 pages
    This document provides an overview of Sun Pharma, the world's 5th largest pharmaceutical company, and discusses key drivers of global pharmaceutical demand and spending. It notes that global pharmaceutical spending is expected to grow to $1400-1430 billion by 2020, driven primarily by improved access and treatment in emerging markets, aging populations, and the treatment of chronic diseases. Developed markets will continue to account for over 60% of global spending, led by the United States.

    Original Description:

    sun pharma gdp variation

    Copyright

    © © All Rights Reserved

    Available Formats

    PPTX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    This document provides an overview of Sun Pharma, the world's 5th largest pharmaceutical company, and discusses key drivers of global pharmaceutical demand and spending. It notes that global pharmaceutical spending is expected to grow to $1400-1430 billion by 2020, driven primarily by improved access and treatment in emerging markets, aging populations, and the treatment of chronic diseases. Developed markets will continue to account for over 60% of global spending, led by the United States.

    Copyright:

    © All Rights Reserved
    Download as PPTX, PDF, TXT or read online from Scribd
    Download as pptx, pdf, or txt
    33 views24 pages

    Sun Pharma

    Uploaded by

    Suman Sourav
    This document provides an overview of Sun Pharma, the world's 5th largest pharmaceutical company, and discusses key drivers of global pharmaceutical demand and spending. It notes that global pharmaceutical spending is expected to grow to $1400-1430 billion by 2020, driven primarily by improved access and treatment in emerging markets, aging populations, and the treatment of chronic diseases. Developed markets will continue to account for over 60% of global spending, led by the United States.

    Copyright:

    © All Rights Reserved
    Download as PPTX, PDF, TXT or read online from Scribd
    Download as pptx, pdf, or txt
    of 24

    SUN

    PHARMA

    GROUP 3J
    Suman Sourav
    Kunal Joshi
    Shivangi Maheshwari Vinay Gundecha
    Ekshan Kumar

    Sun Pharma at glance

    Worlds 5TH largest pharma


    company

    Sun Pharma Today

    Global Manufacturing Footprint

    Ranking in doctor category

    Track record of growth

    Sun Pharma Timeline

    FACTORS
    AFFECTING
    AGGREGATE
    SUPPLY

    Best in class field force productivity

    GDP Data: India, World and US

    Turning around acquisitions

    Key Deals

    Research and Development


    Investment

    ANDP Approvals

    Sustained Profitability Vs Peers

    Developed market patent expiry exposure

    FACTORS
    AFFECTING
    AGGREGATE
    DEMAND

    Global Growth Drivers


    The key contributors of the US$ 349 billion in growth over the next five years will be:
    1. Improving access to modern medicines in pharmerging countries;
    2. Enhanced use of more expensive branded medicines in developed markets; and
    3. Use of cheaper alternatives when loss of exclusivity happens
    Global demand for pharmaceuticals will be driven by:
    . Demographic trends
    . Rise in diagnosis and treatment of chronic conditions
    . Ageing and growing global population
    . Improved access to healthcare
    . Increasing per capita income

    Global Pharma Spending


    Region Wise Spending
    Regions
    Developed Markets
    Pharmerging Markets
    Other Markets
    Global Pharmaceutical
    Market

    2015
    684
    249
    135

    2011-2015 CAGR
    4.80%
    11.90%
    5.20%

    2020
    870-900
    345-375
    150-180

    US $
    billion
    2016-2020
    CAGR
    3-6%
    7-10%
    1-4%

    1069

    6.20%

    1400-1430

    4-7%

    63%
    Contribution of developed markets to global pharmaceutical spending
    Spending and Growth to 2020
    The developed markets will contribute 63% of the spending, driven by the US. Original brands will represent 52%
    of spending and 85% of global spending will be for medicines to treat non-communicable diseases. These
    distributions of costs belie the very different perspective on a volume basis where lower-cost/higher-volume
    medicines dominate the overall use of medicines.

    Global Spending Forecast

    Demand Drivers

    Driving long term growth

    Thank You.

    You might also like